Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Degarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate Cancer

This study has been completed.
Sponsor:
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT01731912
First received: November 19, 2012
Last updated: October 4, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)